Established Medical and Batel Medical officially reached a strategic cooperation.

On September 10th, Olyset Medical and Zhejiang Batel Medical Technology Co., Ltd. officially signed a strategic cooperation agreement in Hangzhou City. In response to the growing demand for cardiovascular disease diagnosis and treatment in the Chinese market, the two parties will establish a strategic partnership, integrate their respective advantageous resources, and focus on the development and promotion of a new generation of interventional technologies represented by "precision diagnosis" and "non-implantation intervention", in order to provide more comprehensive and precise treatment options for Chinese coronary heart disease patients.